Fulgent Genetics (FLGT) Gross Margin (2015 - 2026)

Fulgent Genetics has disclosed Gross Margin across 12 years of filings, most recently posting 30.07% for Q2 2026.

• In Q2 2026, Gross Margin fell 1202.0% year-over-year to 30.07%; the TTM figure through Jun 2026 stood at 47.83% (up 779.0% YoY), while the FY2025 annual figure was 40.56%, up 274.0% from the prior year.
• Gross Margin came in at 30.07% for Q2 2026 at Fulgent Genetics, roughly flat from 30.21% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 8145.5% in Q4 2025 to a low of 15.53% in Q4 2022.
• Average Gross Margin over 5 years is 489.33%, with a median of 37.95% recorded in 2024.
• Year-over-year, Gross Margin sank 5978 bps in 2022 and jumped 810371 bps in 2025.
• Over 5 years, Gross Margin stood at 15.53% in 2022, then jumped by 130 bps to 35.78% in 2023, then rose by 17 bps to 41.79% in 2024, then soared by 19392 bps to 8145.5% in 2025, then sank by 100 bps to 30.07% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 30.07% in Q2 2026, 30.21% in Q1 2026, and 8145.5% in Q4 2025.